Axogen, Inc.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
AXGN$50.89+0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS
AXOGEN, INC.
SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS
THREE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023
| (in thousands) | Balance at Beginning of Year | Additions | Deductions (Charge-offs) | Balance at End of Year |
|---|---|---|---|---|
| Allowance for doubtful accounts | ||||
| 2023 | $650 | $— | $(313) | $337 |
| 2024 | $337 | $650 | $(199) | $788 |
| 2025 | $788 | $400 | $(240) | $948 |
| Valuation allowance for deferred tax assets | ||||
| 2023 | $58,309 | $2,831 | $— | $61,140 |
| 2024 | $61,140 | $315 | $— | $61,455 |
| 2025 | $61,455 | $— | $(557) | $60,898 |
| Reserve for excess and obsolete inventory | ||||
| 2023 | $1,935 | $1,939 | $(2,533) | $1,341 |
| 2024 | $1,341 | $6,989 | $(6,700) | $1,630 |
| 2025 | $1,630 | $4,534 | $(3,962) | $2,202 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.